The conference, to be held on June 28, 2016 at Courtyard Marriott, Mumbai, will deliberate on creative ways to raise awareness and devise strategies to curb the practice of drug counterfeiting
Drug counterfeiting has emerged as a significant problem for all stakeholders in the pharmaceutical industry. This menace causes serious health hazards to the patients while devaluing brand credibility and reducing the trust on the pharma industry.
As a part of a nationwide campaign against drug counterfeiting, PatientSafe India, a one-day conference on addressing the challenge of drug counterfeiting, is being organised at Mumbai. It is slated to be held on June 28, 2016 at Courtyard Marriott, Mumbai International Airport, Mumbai. This conference will be facilitated by SynCore Consulting with active collaboration of all the industry associations, regulators, trade bodies and consumer groups such as OPPI, IDMA, IPA, IMA, PDA and AIOCD. The theme of the conference is to deliberate on the various aspects of drug counterfeiting and suggest creative ways to raise awareness and devise strategies to curb the practice of drug counterfeiting.
The initiative aims to ensure patient safety by addressing the challenge of drug counterfeiting through programmes such as trade meets, round tables and conferences. The initiative also intends to bring together the different stakeholders on a common platform to enable discussions, sharing of insights, best practices and strategies to tackle drug counterfeiting.
The conference is expected to see the presence of eminent speakers from different segments of the pharma ecosystem. Senior representatives from OPPI, AIOCD, IMA, IPA, IDMA, FDA as well as various government agencies, Directors of Policies and Government affairs and senior management professionals from the industry will share their insights on tackling the challenge of drug counterfeiting. Delegates from different segments of the pharma industry will also attend this event. Representatives from various drug packaging and labelling companies, drug regulatory agencies, security and risk management companies and formulation pharma manufacturers will also participate in the event.